Long-term effects of multimodal pain therapy

Organizational Data

DRKS-ID:
DRKS00017685
Recruitment Status:
Recruiting ongoing
Date of registration in DRKS:
2019-08-07
Last update in DRKS:
2022-09-29
Registration type:
Retrospective

Acronym/abbreviation of the study

MMT Longterm

URL of the study

No Entry

Brief summary in lay language

Interdisciplinary multimodal pain therapy is based on the bio-psychosocial pain model and has been established in the treatment of chronic pain in recent years. With the present study, it shall be examined whether, respectively, to which extent there are effects of multimodal pain therapy beyond a time interval of one year after therapy. For the study, all patients, who had been treated in the Interdisciplinary Pain Center, (University Hospital Freiburg) with a multimodal pain therapy of at least four weeks duration within a timeframe of six years are eligible. With a questionnaire, data on pain scores (mean, lowest and highest pain score during the preceding two weeks, pain score regarded as a bearable), depression, anxiety, stress, pain related disability and the current employment status. The data shall be compared to data prior to treatment taken from the patient’s charts. With this study, it should be elucidated whether there is a long term therapeutic effect. Moreover, possible prognostic factors for the long-term effects should be identified.

Brief summary in scientific language

Interdisciplinary multimodal pain therapy is based on the bio-psychosocial pain model and has been established in the treatment of chronic pain in recent years. The efficiency of multimodal pain therapy has been shown in a variety of studies. Systematic reviews showed that regarding pain reduction, the effect sizes of multimodal pain therapy are relatively modest. Larger effect sizes can be reached regarding functionality, and particularly regarding the return to work rate. To date there are only few long term observations with a follow-up of more than one year after multimodal pain therapy. Most studies on multimodal pain therapy do not examine intervals of more than one year after therapy. Already within this timeframe, in some studies, a reduction of the effects induced by multimodal pain therapy was observed. With the present study, it shall be examined whether respectively, to which extent there are effects of multimodal pain therapy beyond a time interval of one year after therapy. For the study, all patients, who had been treated in the Interdisciplinary Pain Center, (University Hospital Freiburg) with a multimodal pain therapy of at least four weeks duration within a timeframe of six years are eligible. With a questionnaire, data on pain scores (mean, lowest and highest pain score during the preceding two weeks, pain score regarded as a bearable), depression, anxiety, stress, pain related disability and the current employment status. The data shall be compared to data prior to treatment taken from the patient’s charts. With this study, it should be elucidated whether there is a long term therapeutic effect. Moreover, possible prognostic factors for the long-term effects should be identified.

Health condition or problem studied

ICD10:
F45.41
Healthy volunteers:
No Entry

Interventions, Observational Groups

Arm 1:
With a questionnaire, data on pain scores (mean, lowest and highest pain score during the preceding two weeks, pain score regarded as a bearable), depression, anxiety, stress, pain related disability and the current employment status.

Endpoints

Primary outcome:
Mean, highest, lowest and acceptable pain strength on the NRS (numerical rating scale) at time of follow-up
Secondary outcome:
Depression/anxiety/stress, quality of life, pain related invalidity, employment status

Study Design

Purpose:
Treatment
Retrospective/prospective:
No Entry
Study type:
Non-interventional
Longitudinal/cross-sectional:
No Entry
Study type non-interventional:
No Entry

Recruitment

Recruitment Status:
Recruiting ongoing
Reason if recruiting stopped or withdrawn:
No Entry

Recruitment Locations

Recruitment countries:
  • Germany
Number of study centers:
Monocenter study
Recruitment location(s):
  • University medical center Interdisziplinäres Schmerzzentrum Freiburg im Breisgau

Recruitment period and number of participants

Planned study start date:
2019-07-21
Actual study start date:
2019-07-21
Planned study completion date:
No Entry
Actual Study Completion Date:
No Entry
Target Sample Size:
500
Final Sample Size:
No Entry

Inclusion Criteria

Sex:
All
Minimum Age:
18 Years
Maximum Age:
80 Years
Additional Inclusion Criteria:
Day hospital multimodal pain therapy in the ISZ between 1.1.2013 and 31.12.2018.

Exclusion Criteria

Incompleteness of questionnaire, severe psychiatric comorbidity, missing language skills to understand questionnaire

Addresses

Primary Sponsor

Address:
Interdisziplinäres Schmerzzentrum Universitätsklinikum Freiburg
Dr. med. Tilman Wolter
Breisacherstr. 64
79106 Freiburg
Germany
Telephone:
+49/761/2705203
Fax:
+49/761/2705013
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry
Investigator Sponsored/Initiated Trial (IST/IIT):
Yes

Contact for Scientific Queries

Address:
Interdisziplinäres Schmerzzentrum UKL Freiburg
PD Dr. med. Tilman Wolter
Breisacherstr.117
79106 Freiburg
Germany
Telephone:
0761/27054801
Fax:
0761/27054990
Contact per E-Mail:
Contact per E-Mail
URL:
https://www.uniklinik-freiburg.de/schmerzzentrum.html

Contact for Public Queries

Address:
Interdisziplinäres Schmerzzentrum UKL Freiburg
PD Dr. med. Tilman Wolter
Breisacherstr.117
79106 Freiburg
Germany
Telephone:
0761/27054801
Fax:
0761/27054990
Contact per E-Mail:
Contact per E-Mail
URL:
https://www.uniklinik-freiburg.de/schmerzzentrum.html

Principal Investigator

Address:
Interdisziplinäres Schmerzzentrum UKL Freiburg
PD Dr. med. Tilman Wolter
Breisacherstr.117
79106 Freiburg
Germany
Telephone:
0761/27054801
Fax:
0761/27054990
Contact per E-Mail:
Contact per E-Mail
URL:
https://www.uniklinik-freiburg.de/schmerzzentrum.html

Sources of Monetary or Material Support

Institutional budget, no external funding (budget of sponsor/PI)

Address:
Interdisziplinäres Schmerzzentrum UKL Freiburg
Breisacherstr.117
79106 Freiburg
Germany
Telephone:
0761/27054810
Fax:
0761/27054990
Contact per E-Mail:
Contact per E-Mail
URL:
https://www.uniklinik-freiburg.de/schmerzzentrum.html

Ethics Committee

Address Ethics Committee

Address:
Ethik-Kommission der Albert-Ludwigs-Universität Freiburg
Engelberger Str. 21
79106 Freiburg
Germany
Telephone:
+49-761-27072600
Fax:
+49-761-27072630
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry

Vote of leading Ethics Committee

Vote of leading Ethics Committee
Date of ethics committee application:
2018-11-19
Ethics committee number:
517/18
Vote of the Ethics Committee:
Approved
Date of the vote:
2019-03-19

Further identification numbers

Other primary registry ID:
No Entry
EudraCT Number:
No Entry
UTN (Universal Trial Number):
No Entry
EUDAMED Number:
No Entry

IPD - Individual Participant Data

Do you plan to make participant-related data (IPD) available to other researchers in an anonymized form?:
Yes
IPD Sharing Plan:
All study data will be published. Raw data will be published as supplementary data.

Study protocol and other study documents

Study protocols:
No Entry
Study abstract:
No Entry
Other study documents:
No Entry
Background literature:
No Entry
Related DRKS studies:
No Entry

Publication of study results

Planned publication:
No Entry
Publikationen/Studienergebnisse:
No Entry
Date of first publication of study results:
No Entry
DRKS entry published for the first time with results:
No Entry

Basic reporting

Basic Reporting / Results tables:
No Entry
Brief summary of results:
No Entry